-
Macrocyclic Hedgehog Inhibitors: SAR and Mechanism
2026-08-19
Dockendorff and colleagues used a modular build-couple-pair strategy to improve macrocyclic Hedgehog pathway inhibitors and identify analogues with stronger cellular activity than robotnikinin. Their combination of structure–activity studies, Ptch-knockout experiments, and competition with SAG and purmorphamine supports Smoothened antagonism for selected compounds, providing a useful framework for mechanism-focused Hedgehog research.
-
PD 173074: FGFR1 Assay Workflow Guide
2026-08-18
PD 173074 combines structure-informed FGFR1 selectivity with measurable VEGFR2 activity for kinase, cell-signaling, angiogenesis, and cancer research workflows. This guide translates its biochemical profile into practical assay design, dose selection, and troubleshooting strategies.
-
Stattic STAT3 Inhibitor: Practical Research Workflows
2026-08-18
Stattic is a practical STAT3 inhibitor for connecting pathway mechanism with apoptosis induction, radiosensitization, and cancer-cell phenotyping. This guide translates STAT3 biology and microbiome-linked signaling evidence into reproducible workflows, assay controls, and troubleshooting decisions.
-
Resibufogenin and NLRP3 in Atherosclerosis
2026-08-17
A 2025 Journal of Advanced Research study reports that resibufogenin limits atherosclerotic disease in ApoE−/− mice by interfering with NLRP3 inflammasome assembly. Integrating animal, macrophage, molecular docking, and surface plasmon resonance experiments, the work connects CYS-279 binding with reduced inflammation, foam-cell formation, and plaque pathology.
-
GKT137831 at the Redox–Ferroptosis Interface
2026-08-17
GKT137831 offers translational researchers a pharmacological way to interrogate Nox1/Nox4-derived oxidative signaling across vascular, fibrotic, and metabolic disease models. This thought-leadership analysis connects its established redox biology with emerging evidence that plasma-membrane lipid remodeling determines ferroptotic execution—while clearly separating validated findings from forward-looking hypotheses.
-
3-Hydroxybutyrate (BHBA) in Stroke Assays
2026-08-16
Use 3-hydroxybutyrate (BHBA) as a defined ketone-body add-back to dissect ferroptosis, neuronal survival, energy metabolism, and chromatin responses. This workflow separates direct metabolite effects from the broader systemic protection produced by remote ischemic postconditioning.
-
MG-132 Workflow for Proteasome and Apoptosis Studies
2026-08-15
Build more informative apoptosis, cell cycle, and oxidative-stress experiments with MG-132, a cell-permeable proteasome inhibitor that enables timed perturbation of intracellular proteostasis. This guide connects dose optimization and orthogonal readouts with the reference study’s key lesson: biological protection is often strongest when complementary response dimensions are measured together.
-
MG-132: Reliable Cell Viability Assay Workflows
2026-08-14
This scenario-driven guide explains how MG-132, SKU A2585, can improve the interpretation of apoptosis, cell-cycle, viability, and oxidative-stress experiments. It covers concentration selection, solvent handling, orthogonal readouts, and practical criteria for choosing a reliable MG-132 source.
-
ARL4C, Synoviocyte Proliferation, and RA
2026-08-14
This study integrates single-cell and bulk transcriptomic data with cellular perturbation, macrophage co-culture, and collagen-induced arthritis experiments to identify ARL4C as a driver of rheumatoid arthritis progression. Its findings connect ARL4C-dependent fibroblast-like synoviocyte proliferation and invasiveness with macrophage polarization, while suggesting a rationale for measuring S-phase entry during mechanistic and pharmacodynamic studies.
-
Phosbind Acrylamide for Mechanistic Protein Analysis
2026-08-13
Phosbind Acrylamide enables antibody-independent analysis of phosphorylation-dependent mobility shifts in SDS-PAGE. This article shows how to apply the phosphate-binding reagent to mechanistic questions such as the CLK4–NEXN axis in pathological cardiac hypertrophy.
-
5-(N,N-dimethyl)-Amiloride in Endothelial Research
2026-08-13
A translational framework for using 5-(N,N-dimethyl)-Amiloride hydrochloride to connect Na+/H+ exchanger biology, intracellular pH regulation, endothelial injury biomarkers, and cardiac ischemia-reperfusion research while maintaining appropriate mechanistic and experimental limits.
-
Rottlerin: PKCδ Signaling as an Entry Checkpoint
2026-08-12
Rottlerin is a PKC inhibitor that can help dissect how protein kinase C signaling connects cell entry, cytoskeletal remodeling, proliferation, and apoptosis. This article develops a causal assay framework grounded in Spiroplasma infection research rather than repeating conventional apoptosis or protocol guidance.
-
GOB-38 Biochemistry and β-Lactamase Specificity
2026-08-12
The reference study characterized GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, by combining genomic analysis, recombinant expression, enzyme profiling, and bacterial co-culture. Its broad β-lactam substrate range, distinctive active-site residues, and potential role in carbapenem-resistance dissemination clarify why this emerging pathogen is important in β-lactam antibiotic resistance research.
-
Radicicol: Mechanism-to-Assay Decision Guide
2026-08-11
Radicicol is an Hsp90 inhibitor and ATPase/kinase probe with applications spanning adipocyte differentiation, ovarian carcinoma apoptosis, and inflammatory research. This guide connects its target biology with the α-KG/LKB1-AMPK senescence study to improve assay design, interpretation, and translational boundaries.
-
LNP-Delivered ABE8e for COL7A1 Correction in DEB
2026-08-11
A 2024 Journal of Investigative Dermatology study evaluated lipid nanoparticles as carriers for ABE8e mRNA and guide RNA to correct pathogenic COL7A1 variants in dystrophic epidermolysis bullosa fibroblasts in vitro. Its main contribution is a formulation-focused demonstration that transient base-editor delivery can produce targeted sequence correction without double-stranded DNA breaks or donor DNA, while also highlighting the experimental constraints that must be addressed before translation.